BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value ($000): $3,529,391 (100.0% shares, 0.0% debt)

Holdings (7)

G GENPACT LIMITED 33.2%

Value ($000) $1,172,770 Shares 40,538,196 Est. Cost $17.18 Unrealized +64.8%

— MICHAELS COS INC 28.7%

Value ($000) $1,012,155 Shares 52,798,929 Est. Cost $17.48 Unrealized —

SGRY SURGERY PARTNERS INC 11.2%

Value ($000) $394,189 Shares 26,455,651 Est. Cost $14.30 Unrealized +17.2%

IQV IQVIA HLDGS INC 10.8%

Value ($000) $380,845 Shares 3,815,315 Est. Cost $101.80 Unrealized -1.9%

— ATENTO S A 9.4%

Value ($000) $332,367 Shares 48,520,671 Est. Cost $10.45 Unrealized —

— VERITIV CORP 4.8%

Value ($000) $170,711 Shares 4,283,840 Est. Cost $50.06 Unrealized —

— FRANKS INTL N V 1.9%

Value ($000) $66,354 Shares 8,506,930 Est. Cost $12.31 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
G	GENPACT LIMITED	40,538,196	$1,172,770	33.2%	$17.18	+64.8%	SHS	G3922B107
—	MICHAELS COS INC	52,798,929	$1,012,155	28.7%	$17.48	—	COM	59408Q106
SGRY	SURGERY PARTNERS INC	26,455,651	$394,189	11.2%	$14.30	+17.2%	COM	86881A100
IQV	IQVIA HLDGS INC	3,815,315	$380,845	10.8%	$101.80	-1.9%	COM	46266C105
—	ATENTO S A	48,520,671	$332,367	9.4%	$10.45	—	SHS	L0427L105
—	VERITIV CORP	4,283,840	$170,711	4.8%	$50.06	—	COM	923454102
—	FRANKS INTL N V	8,506,930	$66,354	1.9%	$12.31	—	COM	N33462107